AChE/BChE/BACE-1-IN-2

Modify Date: 2025-08-21 21:07:39

AChE/BChE/BACE-1-IN-2 Structure
AChE/BChE/BACE-1-IN-2 structure
Common Name AChE/BChE/BACE-1-IN-2
CAS Number 1877000-20-8 Molecular Weight 302.36
Density N/A Boiling Point N/A
Molecular Formula C18H20F2N2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of AChE/BChE/BACE-1-IN-2


AChE/BChE/BACE-1-IN-2 (Compound 4o) is an orally active inhibitor of AChE, BChE, and BACE-1 with IC50 values of 0.069, 0.127 and 0.097 μM against hAChE, hBChE and hBACE-1, respectively. AChE/BChE/BACE-1-IN-2 shows considerable PAS-AChE binding capability, excellent brain permeation, potential disassembly of Aβ aggregates, and neuroprotective activity against Aβ-induced stress. AChE/BChE/BACE-1-IN-2 has remarkable antioxidant potential[1].

 Names

Name AChE/BChE/BACE-1-IN-2

 AChE/BChE/BACE-1-IN-2 Biological Activity

Description AChE/BChE/BACE-1-IN-2 (Compound 4o) is an orally active inhibitor of AChE, BChE, and BACE-1 with IC50 values of 0.069, 0.127 and 0.097 μM against hAChE, hBChE and hBACE-1, respectively. AChE/BChE/BACE-1-IN-2 shows considerable PAS-AChE binding capability, excellent brain permeation, potential disassembly of Aβ aggregates, and neuroprotective activity against Aβ-induced stress. AChE/BChE/BACE-1-IN-2 has remarkable antioxidant potential[1].
Related Catalog
Target

IC50: 0.069 μM (hAChE), 0.097 μM (hBACE-1), 0.127 μM (hBChE)[1]

In Vivo AChE/BChE/BACE-1-IN-2 (Compound 4o) (0-10 mg/kg; p.o.) ameliorates cognitive dysfunction against the scopolamine-induced amnesia model in the Y-maze test[1].
References

[1]. Choubey PK, et al. Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer's disease. Bioorg Med Chem. 2020 Nov 15;28(22):115721.

 Chemical & Physical Properties

Molecular Formula C18H20F2N2
Molecular Weight 302.36
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.